The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative effectiveness and resource utilization of nab-paclitaxel plus gemcitabine (nab-P+G) versus FOLFIRINOX (FFX) in first-line treatment of advanced pancreatic adenocarcinoma (PDAC) in a U.S. community oncology setting.
 
Fadi S. Braiteh
No Relationships to Disclose
 
Manish Patel
No Relationships to Disclose
 
Monika Parisi
No Relationships to Disclose
 
Quanhong Ni
No Relationships to Disclose
 
Si yeon Park
No Relationships to Disclose
 
Claudio Faria
No Relationships to Disclose